Cancer Research & Treatment Fund, Inc. (CR&T) funds research emphasizing the cause, prevention, treatment, and cure of myeloproliferative neoplasms (MPNs) and also funds other blood and solid tumor cancer research.
October 14, 2024
Article
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Darzalex Regimen May Improve MRD Responses in Multiple Myeloma
How to Self Advocate When Insurance Says No to Cancer Treatment Coverage
FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset